The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...
Hosted on MSN1mon
Henry Schein gains amid activist speculation after 13F filing, conference appearanceHenry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products distributor may have attracted an activist investor. The company also ...
Strong Potential of Henry Schein One: Henry Schein’s dental software business, Henry Schein One, has been progressing well, driving robust gains across its core products, including practice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results